EP3768241 - Bibliographic data
COMPOSITION TOPIQUE COMPRENANT CALCIPOTRIOL ET DIPROPIONATE DE BÉTAMÉTHASONE
| Last update | 17/07/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
MC2 Therapeutics Limited James House
Emlyn Lane
Leatherhead
Surrey KT22 7EP
Royaume-Uni
|
|---|---|
| (72) Inventors |
Nigel CRUTCHLEY c/o MC2 Therapeutics Limited
James House, Emlyn Lane
Leatherhead Surrey KT22 7EP
Royaume-Uni
Michelle GEORGIOU c/o MC2 Therapeutics Limited
James House, Emlyn Lane
Leatherhead Surrey KT22 7EP
Royaume-Uni
Stephen LENON c/o MC2 Therapeutics Limited
James House, Emlyn Lane
Leatherhead Surrey KT22 7EP
Royaume-Uni
Morten PRAESTEGAARD c/o MC2 Therapeutics Limited
James House, Emlyn Lane
Leatherhead Surrey KT22 7EP
Royaume-Uni
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP19709992.2 |
|---|---|
| (22) Request date | 18/03/2019 |
| (11) Publication number | EP3768241 |
|---|---|
| Publication date | 08/09/2021 |
| (54) Title of the invention | COMPOSITION TOPIQUE COMPRENANT CALCIPOTRIOL ET DIPROPIONATE DE BÉTAMÉTHASONE |
|---|---|
| (51) International classification | A61K 9/107, A61K 31/593, A61K 31/573, A61K 47/22, A61K 47/10, A61P 17/06 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 18162664 |
|---|---|
| Initial application | None |
| Divisional application | EP21189853.1 /EP3925600 None |
| Expected annuity | Annuity: 8 - Amount: 160 € - Due date 31/03/2026 |
|---|---|
| Last annuity | Annuity: 7 - Payment date 27/02/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 08/09/2021 Constitution de mandataire pour un dossier - Legal date 28/10/2021 |